Association between Vitamin D and mortality risk in gout patients
Journal of Public Health · 2025
DOI: 10.1093/pubmed/fdaf010 ↗Kurz gefasst
Zurückgezogene Publikation in der Zeitschrift Journal of Public Health, 2025. Verfasst von Xinyu Fang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, No. 81 Meishan Road, Shushan District, Hefei, Anhui …. Hauptthemen laut MEDLINE: Gout, Vitamin D, Cardiovascular Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Inflammation and Immune Mediated Diseases Laboratory of Anhui Province Open Project.
Abstract (Originalsprache)
Background
The correlation between gout patients’ 25-hydroxyvitamin D [25(OH)D] levels and their risk of all-cause mortality (ACM) and cardiovascular mortality (CVM) remains inconclusive.
Methods
Data from 7337 gout patients enrolled in the UK Biobank were analyzed, with death data acquired via connection to national death registries. At baseline, serum 25(OH)D levels were measured. We utilized Cox proportional hazards regression to evaluate the correlations between serum 25(OH)D levels and mortality, and mendelian randomization (MR) analyses to explore causality.
Results
During 80 176 person-years of following up (median 11.4 years), 659 all-cause deaths were recorded, including 206 cardiovascular disease-related deaths. We found an L-shaped non-linear inverse connection (P non-linearity<0.05) between serum 25(OH)D levels and ACM and CVM with a cutoff value of 45 nmol/L. In contrast to gout patients with <45 nmol/L, those with 25(OH)D levels ≥45 nmol/L had a significantly decreased likelihood of ACM [Hazard Ratio (HR) 0.72; 95% confidence interval 0.61–0.86]. Nonlinear MR also confirmed the causal connection between sufficient 25(OH)D level threshold (≥50 nmol/L) and a reduced likelihood of ACM. Additionally, raising 25(OH)D over the deficiency thresholds (25 nmol/L) could also potentially mitigate CVM (P trend = 0.02).
Conclusions
Elevated serum 25(OH)D levels are associated with a reduced likelihood of death in gout patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, No. 81 Meishan Road, Shushan District, Hefei, Anhui 230032, China.
- Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, No. 81 Meishan Road, Shushan District, Hefei, Anhui 230032, China.
- School of Public Health, Anhui University of Science and Technology, No. 15 Fengxia Road, Shuangfeng Industrial Zone, Hefei, Anhui 231131, China.
ORCID-Profile: Dongqing Ye
Förderung
- National Natural Science Foundation of China
- Inflammation and Immune Mediated Diseases Laboratory of Anhui Province Open Project
Zitieren
APA
Fang, X., Zhang, J., Zhang, Z., & Ye, D. (2025). Association between Vitamin D and mortality risk in gout patients. Journal of Public Health. https://doi.org/10.1093/pubmed/fdaf010
Vancouver
Fang X, Zhang J, Zhang Z, Ye D. Association between Vitamin D and mortality risk in gout patients. Journal of Public Health. 2025. doi:10.1093/pubmed/fdaf010
BibTeX
@article{Fang2025,
author = {Fang, Xinyu and Zhang, Jie and Zhang, Zixing and Ye, Dongqing},
title = {Association between Vitamin D and mortality risk in gout patients},
journal = {Journal of Public Health},
year = {2025},
doi = {10.1093/pubmed/fdaf010}
}
EUVIMED